Vernakalant
user1asd34123asdsa 2026-11-18T22:54:12+00:00Trade Name: Brinavess Vernakalant is a Class III antiarrhythmic agent administered intravenously for the acute cardioversion of recent-onset atrial fibrillation lasting less than 7 days. It predominantly blocks potassium channels, classifying it as a Class III antiarrhythmic; however, it exhibits an electrophysiologically selective effect on the atrial myocardium. In 2010, its clinical administration was approved [...]